|
 |
KeflexThis page contains recent news articles, when available, and an overview of Keflex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Keflex (when available) Cefuroxime, a second-generation cephalosporin, is used to treat severe upper and lower respiratory tract infections, skin infections, otitis media, and surgical prophylaxis. For the treatment of the following infections (respiratory, skin, soft tissue, urinary tract infections, ear, nose, throat infectsion) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A ß-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staph. Also used to treat acute bacterial bronchitis in patients with COPD Mechanism Of Action: Cefuroxime, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefuroxime interferes with an autolysin inhibitor. News Articles on Cefuroxime MiddleBrook Pharmaceuticals Reports Inducement Grants Under NASDAQ Marketplace ... - 05 Jan 2010 MiddleBrook currently markets KEFLEX, the immediate-release brand of cephalexin, and MOXATAG –the first and only FDA-approved once-daily amoxicillin. ... Earthtimes (press release) MiddleBrook Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript - Nov 5, 2009 Net sales of MOXATAG for the third quarter of 2009 totaled negative $576000, while net sales of the KEFLEX franchise totaled $1.7 million. ... Seeking Alpha (blog) Ask, 'What's up, Doc?' - Nov 3, 2009 The physician notes cellulitis, starts Keflex, and the symptoms resolve. Keflex is the only order documented. The doctor has just saved the Medicare system ... McKnight's Long Term Care News Recurrent cellulitis following buttock augmentation - Nov 3, 2009 The woman was discharged home on oral cephalexin (Keflex) for one week. On re-admission, Ms. P's temperature was 99.1ºF, pulse 76 beats per minute, ... Clinical Advisor Overuse of antibiotics resulting in newer, more resistant bacteria - Oct 30, 2009 MRSA's "main attribute," he continued, "is its resistance to the old-fashioned antibiotics such as penicillin and Keflex." The CDC states that people ... Gloucester Daily Times المرأة الØامل..وسلامة تناول المضادات الØيوية - Nov 12, 2009 Ù€ «كيÙ?الوسبورين»، مثل: «كيÙ?لكس» KeflexØŒ «سيكلور» CeclorØŒ أو غيرهما. Ù€ «إريثرومايسن» بكاÙ?Ø© أنواعه. Ù€ «أزيثرومايسن» azithromycin أو ما ÙŠÙ?عرÙ? بـ«زيثروماكس» ... بلاغ Tras aval de CFC, Pfizer ya opera con Wyeth, México su primer mercado ... - Oct 22, 2009 El catálogo es enorme con el Viagra, Tafil, Cialis, Dolo-Neurobion, Buscapina, Pentrexyl, Terramicina, Mesulid, Singulair, Crestor, Keflex, Rocephin, ... Milenio Con cambios internos SCT puede empujar TV digital y más canales, derechos de ... - Oct 23, 2009 Ahà está Cialis, competencia del Viagra, y que es de Eli Lilly que lleva Carlos Baños, lo mismo que el Keflex. Buscapina y Mesulid son de Boehringer que ... Milenio … Receives FDA Approval Letter for New Strengths of Antibiotic Keflex... - May 15, 2006 The new Keflex (cephalexin) 750mg strength provides healthcare ... Keflex is approved for adult dosages ranging from one to four grams per day in divided ... DG News Advancis sees 2006 Keflex sales below prior view - Jan 12, 2007 Jan 12 (Reuters) - Advancis Pharmaceutical Corp. AVNC.O on Friday lowered its revenue estimates from its Keflex antibiotic products for 2006, saying sales ... Reuters … Receives FDA Approval Letter For New Strengths of Keflex - May 18, 2006 The new Keflex (cephalexin) 750mg strength provides healthcare ... Keflex is approved for adult dosages ranging from one to four grams per day in divided ... DentalPlans.com How is cystitis treated? - Dec 4, 2008 ...their brand names) include: trimethoprim (Trimopan), nitrofurantoin (Furadantin, Macrobid, Macrodantin), cefalexin (Ceporex, Keflex) and amoxicillin. ... guardian.co.uk Advancis Starting Another Trial, Selling Keflex Rights For $12M - Sep 16, 2005 By Jennifer Boggs. After the product, which combines the antibiotic amoxicillin with the company's once-a-day controlled-release Pulsys technology, ... BioWorld Online - BioWorld Online Advancis' Keflex deal doesn't look promising - Jan 6, 2006 Advancis Pharmaceutical's bid to sell the US rights of a popular antibiotic to a private company isn't looking so good. Germantown-based Advancis (NASDAQ: ... Washington Business Journal MiddleBrook Pharmaceuticals wins OK from FDA - Jan 24, 2008 While the company has been selling several doses of Keflex, a drug it bought from Eli Lilly & Co. in 2004, it sold the rights to that drug to investors to ... Bizjournals.com Smith v. Municipality of Lycoming County, No. 1:05-CV-1729 (MDPa. 08/... - Aug 24, 2007 In early May 2004, he requested that the Keflex be discontinued. (Doc. ... He gave Smith the option to refuse the Keflex if he felt it was appropriate. ... $2.95 - U.S. District Court, Middle District of... - VersusLaw Advancis Slashes Guidance - Oct 13, 2006 The Germantown, Md., company said it expects 2006 Keflex sales of $7 million to $10 million, down from the earlier $16.5 million target. ... TheStreet.com - TheStreet.com (subscription) Advancis to look at financing options - Mar 27, 2007 The company now sells a skin infection treatment, Keflex, whose latest approved dosage has yielded lower-than-expected returns in the last eight months. ... Bizjournals.com MIDDLEBROOK STOCK SOARS 139% OVER TIME-RELEASE … - Jan 25, 2008 When it completes its strategic process, MiddleBrook hopes to have a partner who can finance a pivotal test of timed-released Keflex, a version of another ... Pay-Per-View - The Sun - ProQuest Archiver Advancis Pharmaceutical Provides Update on Keflex Launch. - Oct 13, 2006 GERMANTOWN, Md., Oct. 13 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation , a pharmaceutical company focused on developing and commercializing ... Free with registration - PR Newswire - AccessMyLibrary.com … : Advancis Pharmaceutical Corporation Launches Keflex(R) Powder for... - Jun 8, 2005 Advancis Pharmaceutical Corporation Launches Keflex(R) Powder for Oral Suspension in the United States. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Advancis Pharmaceutical Corporation Launches Keflex(R) Powder for … - Jun 8, 2005 GERMANTOWN, Md., June 8 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation , a pharmaceutical company focused on developing and commercializing ... $4.95 - PR Newswire - ECNext Advancis Pharmaceutical Announces Launch of Keflex 750mg Capsules. - Jul 25, 2006 GERMANTOWN, Md., July 25 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation , a pharmaceutical company focused on developing and commercializing ... Free with registration - PR Newswire - AccessMyLibrary.com MiddleBrook narrows loss, considers future - Mar 4, 2008 Revenue in 2007 was generated by sales of Keflex, a drug whose rights MiddleBrook purchased. Moxatag is the first drug MiddleBrook has developed. ... Bizjournals.com … Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III... - Jun 26, 2007 Advancis Pharmaceutical Reports on Meeting with FDA Reviewing Keflex PULSYS Phase III Trial Design. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Inc acquires Deerfield Management-Keflex from Deerfield Management... - Sep 4, 2008 US - MiddleBrook Pharmaceuticals Inc (MP) acquired the Keflex assets of Deerfield Management, a hedge fund firm, for an estimated $## mil. Pay-Per-View - deals - Alacra Store Advancis Pharmaceutical Provides Update on Keflex Brand - Jan 5, 2006 GERMANTOWN, Md., Jan. 5 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation , a pharmaceutical company focused on developing and commercializing ... RedOrbit Advancis Pharmaceutical to Conduct Additional Adult Amoxicillin … - Sep 15, 2005 Advancis also announced that it has reached an agreement in principle to sell the US rights to the Keflex(R) brand of cephalexin to a private company. ... $4.95 - PR Newswire - ECNext Q2 2006 Advancis Pharmaceutical Corporation Earnings Conference Call … - Aug 2, 2006 Following my introductory remarks, Dr. Rudnic will speak to our Phase III clinical trial and the status of our recently launched Keflex 750mg product. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com … Agreement With MiddleBrook Pharmaceuticals for Keflex(R) 750 mg - Jan 7, 2008 Cephalexin, the generic form of Keflex, is the third most prescribed outpatient ... Keflex is indicated for treatment of the following infections: ... Web Services Journal - Web Services Journal Advancis Pharmaceuticals reports disappointing sales of Keflex - Jan 16, 2007 It appears Advancis Pharmaceuticals Inc.'s new antibiotic formulation hasn't proven to be the cash cow the company has hoped. ... $2.95 - Daily Record - NewsBank Q4 2005 Advancis Pharmaceutical Corporation Earnings Conference Call … - Feb 9, 2006 We could continue negotiating for the sale of Keflex with a private company, ... Advancis' Keflex assets include the exclusive rights to manufacture, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, … - Jan 8, 2008 Cephalexin, the generic form of Keflex, is the third most prescribed outpatient ... Keflex is indicated for treatment of the following infections: ... Free with registration - M2 Presswire - AccessMyLibrary.com Advancis Pharmaceutical Provides Update on Additional Keflex Products - Apr 21, 2006 GERMANTOWN, Md., April 21 /PRNewswire-FirstCall/ -- Advancis Pharmaceutical Corporation , a pharmaceutical company focused on developing and commercializing ... RedOrbit Press Release: Advancis Pharmaceutical Announces Preliminary 2006 … - Jan 12, 2007 Total revenue for 2006 from sales of Keflex products was approximately $5 million, ... 200 ml bottle Keflex is available ... or to order Keflex Powder for . ... Pay-Per-View - PR Newswire - HighBeam Research "Super bug" infects wider Inland population - Jan 29, 2005 Though its cousin CA-MRSA is resistant to Keflex and penicillin, other easily available and affordable antibiotics, including sulfa, doxycycline and ... $3.50 - Inland Valley Daily Bulletin - NewsBank … Pharmaceutical Provides Update on Keflex Launch. - PR Newswire | … - Oct 13, 2006 Advancis Pharmaceutical Provides Update on Keflex Launch. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Advancis Pharmaceutical Reports First Quarter 2007 Results. - May 8, 2007 Since its introduction, the number of prescriptions filled with Keflex 750mg ... FINANCIAL DETAILS -- Total revenue, resulting entirely from net Keflex ... $4.95 - PR Newswire - ECNext … Pharmaceutical Announces Launch of Keflex 750mg Capsules. - PR … - Jul 25, 2006 Advancis Pharmaceutical Announces Launch of Keflex 750mg Capsules. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Cornerstone buys US drug license from Japanese firm - Nov 10, 2006 ...citing increased expenses brought on by the US Food and Drug Administration's insistence on an additional clinical trial for a drug called Keflex. ... Bizjournals.com Advancis Pharmaceutical Changes Its Name to MiddleBrook … - Jun 28, 2007 ...marketing our branded Keflex antibiotic franchise, and positioning our other ... capital and continue as a going concern, (2) increase Keflex 750 sales, ... $4.95 - PR Newswire - ECNext Mayo Clinic expertise - Jun 26, 2008 ...amoxicillin (Amoxil, Trimox), azithromycin (Zithromax), clarithromycin (Biaxin), clindamycin (Cleocin) or a cephalosporin (Keflex, Ceclor). ... MayoClinic.com Other brand name: Keftab - Dec 1, 2005 Keflex is available in capsules and an oral suspension form for use in children. ... Keflex may be taken with or without meals. However, if the drug upsets ... Free with registration - PDR Family Guide to Prescription Drugs - AccessMyLibrary.com MiddleBrook Pharmaceuticals sells product line to bolster financial … - Nov 8, 2007 MiddleBrook Pharmaceuticals Inc. is selling its Keflex antibiotic line to a ... MiddleBrook can buy back its Keflex line, which treats skin infections, ... Bizjournals.com Advancis Pharmaceutical Signs Contract Sales Agreement With Innovex. - Jun 22, 2006 The new Keflex (cephalexin) 750mg strength provides healthcare ... Keflex is approved for adult dosages ranging from one to four grams per day in divided ... Free with registration - PR Newswire - AccessMyLibrary.com Docs on trial in civil case A lawsuit alleges malpractice led to... - Mar 5, 2008 He prescribed Percocet, a painkiller, and Keflex, an antibiotic. At a follow-up appointment four days later, Rutter found drainage and pus coming from his ... $1.95 - York Daily Record/York Sunday News/York... - NewsBank Advancis Pharmaceutical shares plunge after FDA rejects drug … - Feb 15, 2007 Keflex drew just $5 million in sales for the year, lower than previous expectations of $7 million to $10 million in revenue. ... $2.95 - Daily Record - NewsBank Business Update; Advancis Pharmaceutical launches Keflex 750mg … - Aug 29, 2006 2006 AUG 29 - (NewsRx.com) -- Advancis Pharmaceutical Corp. (AVNC) announced the commercial launch of Keflex 750mg capsules. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones … Pharmaceutical Provides Update on Keflex Brand. - PR Newswire | … - Jan 5, 2006 Advancis Pharmaceutical Provides Update on Keflex Brand. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Keflex Capsules.(NOW AVAILABLE)(Brief article) - Sep 4, 2006 Keflex Capsules are now available in 750 mg for treating respiratory tract infections, otitis media, skin and skin structure infections, bone infections, ... Free with registration - Drug Topics - AccessMyLibrary.com … Corp. launches 750-mg Keflex capsules)(Baxter Healthcare Corp.... - Jun 19, 2006 The antibiotic Keflex (cephalexin capsules, USP) is now available in 750-mg strength. ... Keflex had already been approved in strengths of 250 and 500 mg. ... Free with registration - Drug Topics - AccessMyLibrary.com Advancis Pharmaceutical Reports Third Quarter 2006 Results. - Nov 1, 2006 Advancis reported third quarter 2006 net Keflex product sales of $2.4 million, ... In addition to product sales of Keflex, in the prior year Advancis ... $4.95 - PR Newswire - ECNext Germantown-based MiddleBrook Pharmaceuticals cuts loss - Aug 3, 2007 MiddleBrook attributed the nearly nine-fold increase in revenue to strong sales of its antibiotic Keflex, which it launched in 750-milligram strength ... $2.95 - Daily Record - NewsBank Keflex 750-mg tablets.(PRODUCTS) - Jul 1, 2006 The Food and Drug Administration has approved cephalexin capsules (Keflex) in 750-mg capsules for the treatment of skin infections. ... Free with registration - Skin & Allergy News - AccessMyLibrary.com Advancis Pharmaceutical Reports Third Quarter 2005 Results. - Oct 27, 2005 Advancis reported total net Keflex revenue of $1.2 million in the third ... The Company has agreed to terms for the sale of its Keflex assets and has ... Free with registration - PR Newswire - AccessMyLibrary.com … Provides Update on Additional Keflex Products. - PR Newswire | … - Apr 21, 2006 Advancis Pharmaceutical Provides Update on Additional Keflex Products. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Keflex Capsules. - Sep 4, 2006 Keflex Capsules are now available in 750 mg for treating respiratory tract infections, otitis media, skin and skin structure infections, bone infections, ... $9.94 - Drug Topics - Alacra Store Keflex Capsules.(NOW AVAILABLE)(Brief article) - Sep 4, 2006 Advancis Pharmaceutical Corp., Germantown, Md., (301) 944-6600, has approval for a new dosing strength of its anti-infective product Keflex (cephalexin USP) ... $4.95 - Drug Topics - ECNext Advancis Pharmaceuticals' prospects get boost with new drug trials - Aug 11, 2006 Now, thanks to amoxicillin's market path and sales of the company's other drug Keflex, the newly confident Advancis expects to break even by next year and ... Baltimore Business Journal Article: Keflex 750-mg tablets.(PRODUCTS) - Skin & Allergy News | … - Jul 1, 2006 Keflex 750-mg tablets.(PRODUCTS) ... find Skin & Allergy News articles. The Food and Drug Administration has approved cephalexin capsules (Keflex) in 750-mg ... Pay-Per-View - Skin & Allergy News - HighBeam Research Advancis Pharmaceutical Reports Second Quarter 2005 Results. - Aug 4, 2005 Late in the second quarter, Advancis launched Keflex(R) Powder for Oral ... The launch marks the return of great-tasting Keflex oral suspension to the ... $4.95 - PR Newswire - ECNext … Receives FDA Approval Letter for New Strengths of Keflex. - PR … - May 15, 2006 Commercial Launch of New Keflex 750mg Capsules Underway ... approval of the Company's ... Application (NDA) for two new Keflex strengths -- 333mg . ... Pay-Per-View - PR Newswire - HighBeam Research Germantown-based Advancis Pharmaceutical to learn soon the future of ... - Jun 7, 2006 Bannon said at one point Advancis intended to sell the Keflex brand it purchased for $11 ... Last month the FDA approved a new, stronger dosage of Keflex, ... $2.95 - Daily Record - NewsBank How to take Penicillin G Potassium or Sodium Injection from Consumer ... - Jan 8, 2006 ...tell your doctor and pharmacist if you are allergic to penicillin, cephalosporins [eg, cefaclor (Ceclor), cefadroxil (Duricef), or cephalexin (Keflex)], ... consumerreports.org New treatment algorithm improves clinical outcomes in MRSA cases.( … - Dec 1, 2006 The recommended treatment was cephalexin (Keflex) plus trimethoprim-sulfamethoxazole (TMP/SMX). * Type 2: Uncomplicated abscesses. ... Pay-Per-View - Skin & Allergy News - Factiva, from Dow Jones … receives US FDA approval letter for new strengths of Keflex - Jun 12, 2006 The new Keflex (cephalexin) 750mg strength provides healthcare professionals a ... Keflex is approved for adult dosages ranging from 1 to 4 grams per day in ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones … receives US FDA approval letter for new strengths of Keflex - Jun 16, 2006 The new Keflex (cephalexin) 750mg strength provides healthcare professionals a ... Keflex is approved for adult dosages ranging from 1 to 4 grams per day in ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Advancis Pharmaceutical Reports First Quarter 2006 Results. - May 2, 2006 ..."We believe an FDA action on the application for our new Keflex products will ... Advancis reported net Keflex sales of $0.9 million in the first quarter of ... $4.95 - PR Newswire - ECNext Collaborations; Pharmaceutical firm signs supply agreement with Ceph ... - Jan 25, 2005 With the agreement, Advancis has secured a long-term supply for its Keflex (cephalexin capsules, USP) brand of products beyond the transitional period ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Moxatag approval a crucial first for MiddleBrook - Jan 28, 2008 Keflex has provided MiddleBrook with a revenue stream as it pursues its Pulsys development programme. The line was extended with a 750mg capsule formulation ... In-PharmaTechnologist.com Advancis Pharmaceutical公布06å¹´Keflex产å“?销售é¢? - Jan 12, 2007 ...å…¬å?¸å…¬å¸ƒï¼Œ2006年全年Keflex产å“?销售é¢?约为500万美元，低於公å?¸å…ˆå‰?预期的700-1000万 美元区间。2006年产å“?销售净收入包括下列è?¯å“?的销售é¢?：Keflex250mg与500mg，新 ... 金èž?ç•Œ Collaborations; Pharmaceutical firm signs supply agreement with Ceph ... - Jan 24, 2005 With the agreement, Advancis has secured a long-term supply for its Keflex (cephalexin capsules, USP) brand of products beyond the transitional period ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones Advancis Pharmaceutical Corporation at Lehman Brothers Ninth Annual … - Mar 8, 2006 We have a franchise of products, Keflex, that we bought from Eli Lilly back ... And these new products, new Keflex products that are going to enhance that ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Advancis deadline nears to fix name - Oct 20, 2006 Last week, Advancis also announced that its retail stocking of Keflex 750 was ... Keflex sales will be between $7 million and $10 million, down from the ... Business Gazette Loislaw Federal District Court Opinions - PODGURSKI v. US (Md. 2005) - Sep 21, 2005 61-62; id., Ex. B, Keflex prescription.) Keflex, a cephalosporin, is contraindicated in patients with known allergies to cephalosporins and penicillin. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Before the Bell Report for Tuesday, January 8th, 2008 - On the Radar:... - Jan 8, 2008 Cephalexin, the generic form of Keflex, is the third most prescribed outpatient ... Keflex is indicated for treatment of the following infections: ... $4.95 - M2 Presswire - ECNext Advancis Pharmaceutical Corporation at Thomas Weisel Partners … - Sep 8, 2006 We have a Keflex franchise. We bought Keflex, which is the third most widely ... We've just accomplished one with our Keflex 750 mg product launch. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com … ) Concludes Pre-Phase III Meeting with FDA for Development of Keflex... - Jun 26, 2007 Based on the outcome of the meeting, the Company believes its planned non-inferiority Phase III clinical trial design and its regulatory strategy for Keflex ... StreetInsider.com - StreetInsider.com (subscription) MiddleBrook Pharmaceuticals Reports Second Quarter 2007 Results. - Aug 2, 2007 FINANCIAL DETAILS -- Total revenue, resulting entirely from net Keflex ... Increased product sales were mainly attributable to the Company's Keflex 750 mg ... Free with registration - PR Newswire - AccessMyLibrary.com Advancis Pharmaceutical Reports Fourth Quarter and Full Year 2004 … - Feb 10, 2005 Advancis reported net Keflex sales of $1.3 million in the fourth quarter and a total ... Advancis has initiated a research program for a once-a-day Keflex ... $4.95 - PR Newswire - ECNext MiddleBrook Pharmaceuticals Announces $100 Million Investment to … - Jul 1, 2008 The Company will reacquire the Keflex assets as well as its ongoing royalty obligations to Deerfield for approximately $11 million . ... Genetic Engineering News - Genetic Engineering News (press release) Loislaw Federal District Court Opinions - PIERCE v. COOK (EDOkla. 10-... - Oct 30, 2007 He was prescribed Keflex, an antibiotic, and instructed to take Tylenol as ... Plaintiff stated in his deposition that he did not know that Keflex is an ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw After rocky year, Advancis Pharmaceutical Corp. casts an eye to the... - Aug 14, 2006 A second big piece of Advancis' plan is Keflex, another of its antibiotics. At one point, the company strongly considered selling the Keflex brand for $15 ... $2.95 - Daily Record - NewsBank Advancis Pharmaceutical Corporation.(Update) | Article from Medical … - Aug 1, 2006 Advancis Pharmaceutical has acquired the U.S. marketing rights to the antibiotic Keflex (cephalexin capsules) from Eli Lilly for $11 million. ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Skittish about biotech, investors drive Advancis Pharmaceutical stock... - May 23, 2006 Xu said the new Keflex line extension is a good temporary cushion for the company. Still, Advancis investors may be feeling the same anxiety as other ... $2.95 - Daily Record - NewsBank Finance; Anti-infective drug maker posts 48% increase in revenue - Mar 7, 2006 Product sales from the company's Keflex antibiotic were $1.6 million in the ... "We believe that new Keflex products that have already been filed for FDA ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Cornerstone BioPharma lays off 35% of work force - Jan 20, 2006 With the Keflex project dead, sales people hired in anticipation of ... Cornerstone was seeking approval for an alternate form of Keflex when it ran into ... Triangle Business Journal Treatment issues with hepatitis C - Jul 3, 2006 The doctor prescribed Keflex to be taken before dental procedures. ... They told me I had an allergic reaction to the Keflex, a penicillin-type drug. ... Sarasota Herald-Tribune Germantown, Md.-based drugmaker stock falls after product falls... - Jan 6, 2006 Instead, Advancis said it will hang on to Keflex, create new products from it and look for project partners to help pay for them. ... Pay-Per-View - Baltimore Sun - HighBeam Research Adobe Systems, Movie Gallery active late - MarketWatch - Sep 15, 2005 During the regular session, the company said it agreed to sell the US rights to its Keflex brand of cephalexin to a private company. ... MarketWatch MiddleBrook Pharmaceuticals Closes Private Placement of Common … - Jan 30, 2008 The Company currently markets the Keflex(R) brand of cephalexin and has received regulatory approval for MOXATAG(TM) -- the first and only once-daily ... Free with registration - PR Newswire - AccessMyLibrary.com Finance; Advancis Pharmaceutical reports net loss of $0.35 per share - Aug 29, 2006 Advancis reported second quarter 2006 net Keflex product sales of $0.3 million, ... In addition to product sales of Keflex, in the prior year Advancis ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Third name change didn't work out for Advancis Pharmaceuticals - Oct 2, 2006 Advancis makes the antibiotic Keflex. Its lead product candidate, ... Implied is Ketek's similarity in name to Keflex, Advancis' sole commercial product. ... $2.95 - Daily Record - NewsBank Md.-based Advancis Pharmaceutical Corp. freezes development, looks … - Mar 29, 2007 Its revenue for the year from Keflex sales was $4.8 million, ... The company has faced challenges of late including disappointing Keflex sales, ... Pay-Per-View - Daily Record - HighBeam Research Press Release: Advancis Pharmaceutical Reports Third Quarter 2006 … - Nov 1, 2006 Advancis reported third quarter 2006 net Keflex product sales of $2.4 million, ... In addition to product sales of Keflex, in the prior year Advancis ... Pay-Per-View - PR Newswire - HighBeam Research Md.-based Advancis Pharmaceutical Corp. freezes development, looks … - Mar 29, 2007 Its revenue for the year from Keflex sales was $4.8 million, ... The company has faced challenges of late including disappointing Keflex sales, ... $2.95 - Daily Record - NewsBank Personnel; Advancis Pharmaceutical strengthens sales capability with ... - Mar 28, 2006 As we continue to advance our Keflex and Amoxicillin Pulsys product candidates, their combined experience in launching products and building commercial ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones MD-based Advancis Pharmaceutical's stock price soars, but why? - Mar 23, 2006 But the Keflex franchise cushion "is definitely the right thing to do. All this they've been doing is to protect from the downside," Xu said. ... $2.95 - Daily Record - NewsBank Article: Low-tech name likely for Germantown-based Advancis … - Jun 14, 2007 Most costly will be relabeling the entire existing supply of Keflex. The firm is skipping a major rebranding campaign, Bannon said, noting Advancis is ... Pay-Per-View - Daily Record - HighBeam Research CHAT LIVE with other shareholders about: (OTCBB: ARGA), (OTCBB: … - Jan 9, 2008 Cephalexin, the generic form of Keflex, is the third most prescribed outpatient antibiotic in the US, with approximately 25 million prescriptions written ... Free with registration - M2 Presswire - AccessMyLibrary.com Press Release: FDA Approves Allegra(R) (fexofenadine hydrochloride) … - Oct 18, 2006 Article: Advancis Pharmaceutical Corporation Launches Keflex(R) Powder for ... ... Keflex Powder for Oral Suspension is 25 to 50 milligrams . ... Pay-Per-View - PR Newswire - HighBeam Research Bellwether Report.com is Looking at Advancis Pharmaceutical Corp. - Oct 17, 2006 Advancis said sales of its recently approved antibiotic Keflex were slower than expected in August and September, prompting the company to lower by half its ... Free with registration - M2 Presswire - AccessMyLibrary.com Advancis' resolution: New name, new product - Dec 29, 2006 It also reported increased sales of its Keflex antibiotic product to $2.4 million for ... To distribute Keflex 750, the company recently set up a sales and ... Business Gazette Advancis brings back Bruno - Feb 28, 2006 Its marketed product, Keflex, is an antibiotic used to treat a variety of infections, including respiratory tract infections, ear infections, ... Washington Business Journal Q2 2007 MiddleBrook Pharmaceuticals, Inc. Earnings Conference Call - ... - Aug 2, 2007 With respect to our Keflex product for adults with uncomplicated skin ... Having determined the dosing and duration of a once-daily Keflex product that we ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Finance; Pharmaceutical firm reports 213% increase in 2004 revenue - Mar 11, 2005 In addition, we continue to establish sales, marketing, and distribution capabilities for Keflex, all of which support preparation for the future launch of ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Finance; Pharmaceutical firm reports 213% increase in 2004 revenue - Mar 8, 2005 In addition, we continue to establish sales, marketing, and distribution capabilities for Keflex, all of which support preparation for the future launch of ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Loislaw Federal District Court Opinions - MILEY v. JONES COUNTY JAIL ... - Jul 25, 2007 Dr. Patel told plaintiff that he would be prescribed Keflex, an antibiotic. According to plaintiff, however, he did not receive any Keflex at this time. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Brand Names/Synonyms: Keflex is also known by the following brand names and/or synonymsAncef; Biofuroksym; Ceclor; Ceclor Cd; Cedax; Cefditoren; Cefizox; Cefotan; Ceftin; Ceftizoxime Sodium; Cefurax; Cefuril; Cefuroxim; Cefuroxime; Cefuroxime Axetil; Cefuroxime Free Acid; Cefuroxime Sodium; Cefuroxime Sodium Salt; Cefuroxime [Usan:Ban:Inn]; Cefuroxime and Dextrose in Duplex Container; Cefuroximo [Inn-Spanish]; Cefuroximum [Inn-Latin]; Cefzil; Cephuroxime; Ceptaz; Duricef; Elobact; Fortaz; Keflex; Keftab; Kefurox; Kefurox in Plastic Container; Kerurox; Mandol; Maxipime; Mefoxin; Monocid; Omnicef; Oraxim; Rocephin; Sharox; Tazicef; Vantin; Velosef; Zinacef; Zinacef Danmark; Zinacef in Plastic Container; Zinat; Zinnat Drug Category: Keflex is categorized under the following by the FDA: Anti-bacterial Agents; Cephalosporins; ATC:J01DC02 Dosage Forms: POWDER; POWDER FOR SOLUTION; TABLET Absorption: Well absorbed from the GI tract (bioavailability is 37-52%) Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 4-(carbamoyloxymethyl)-8-[2-(2-furyl)-2-methoxyimino-acetyl]amino-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
